Literature DB >> 1742128

Powdered diatrizoic acid for radiography of the respiratory tract. Part II. Clinical application.

W Szmigielski1, M Klamut, M Dahniya, S Klonowski, F Furmanik, K Kupisz, O Mahdi.   

Abstract

The diagnostic and clinical value of 41 examinations using insufflation and/or inhalation of powdered diatrizoic acid for tracheobronchography, tracheography, laryngography, nasopharyngography, and sinusography was investigated in 35 patients. Diatrizoic acid was found to be useful when applied by insufflation for demonstration of the nasopharynx, trachea and greater bronchi, especially in patients with airway stenosis and low pulmonary reserve. Double contrast images were obtained with good demonstration of anatomic details and adequate diagnostic value. Visualization of the peripheral bronchi by insufflation was satisfactory only when excessive secretions were not present. The inhalation method was adequate only for visualization of the trachea and main bronchi. The method was found to be safe since diatrizoic acid produced no toxic, allergic or febrile reactions and was given in relatively small amounts without impairment of respiratory function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1742128

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  3 in total

1.  Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent.

Authors:  Nashwa El-Gendy; Kristin L Aillon; Cory Berkland
Journal:  Int J Pharm       Date:  2010-03-07       Impact factor: 5.875

2.  Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization.

Authors:  Kristin L Aillon; Nashwa El-Gendy; Connor Dennis; Jeffrey P Norenberg; Jacob McDonald; Cory Berkland
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

3.  The Utility of Pulse Fluoroscopy During Mediport Insertion to Diagnose Air Embolism.

Authors:  Mihika Shah; Enrique J Pantin
Journal:  Turk J Anaesthesiol Reanim       Date:  2022-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.